Project Details
| Status | Active |
|---|---|
| Effective start/end date | 09/4/24 → 11/16/26 |
Funding
- TWI Biotechnology Incorporated: $14,725.00
An International, Multicenter, Randomized, Double-Blind, Parallel Group, VehicleControlled, Phase 2/3 Study with Open-Label Extension Evaluating the Efficacy and Safety of Diacerin 1% Ointment for the Treatment of Generalized EBS
- Slutsky, Jordan (PI)
- Kaufmann, Tara (CoPI)
- Hayman, Robert (CoPI)
Project: Research